Search Results - "Stringer, C.A"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Phase I Study of Alternating Doublets of Topotecan/Carboplatin and Paclitaxel/Carboplatin in Patients with Newly Diagnosed, Advanced Ovarian Cancer by Gordon, Alan N., Hancock, Kenneth C., Matthews, Carolyn M., Messing, Mark, Stringer, C.A., Doherty, Mark G., Teneriello, Michael

    Published in Gynecologic oncology (01-04-2002)
    “…Objective. The aim of this study was to evaluate topotecan with carboplatin in an alternating doublet with carboplatin and paclitaxel in first-line ovarian…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis by Stringer, C A, Gershenson, D M, Burke, T W, Edwards, C L, Gordon, A N, Wharton, J T

    Published in Gynecologic oncology (01-09-1990)
    “…Between October 1985 and January 1989, 33 patients with stage I (31) or clinically occult stage II (2) endometrial cancer at a high risk for recurrence were…”
    Get more information
    Journal Article
  5. 5

    Hyperfractionated split-course whole abdominal radiotherapy for ovarian carcinoma: tolerance and toxicity by Kong, J S, Peters, L J, Wharton, J T, Ang, K K, Delclos, L, Gershenson, D M, Copeland, L J, Edwards, C L, Freedman, R S, Saul, P B

    “…Whole abdominal irradiation after chemotherapy and second look laparotomy for advanced ovarian carcinoma is poorly tolerated because of hematologic toxicity…”
    Get more information
    Journal Article
  6. 6